Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H J Stauss

Showing results (1-10 of 50) with videos related to

Pageof 5
Sort By:
Immunology Today|April 22, 1999
Immunotherapy with CTLs restricted by nonself MHCH J Stauss
Journal of the National Cancer Institute|December 20, 1995
Mutant Ras proteins and peptides: bad news for tumorsH J Stauss
Clinical and Experimental Immunology|July 27, 2001
Benign autoimmunity to combat malignancyH J Stauss
Current Biology : CB|October 1, 1991
Peptides feeling groovyH J Stauss
Proceedings of the National Academy of Sciences of the United States of America|November 12, 1996
Peptide-specific cytotoxic T lymphocytes restricted by nonself major histocompatibility complex class I molecules: reagents for tumor immunotherapyE Sadovnikova, H J Stauss
The Journal of Experimental Medicine|May 1, 1993
Identification of two cytotoxic T lymphocyte-recognized epitopes in the Ras proteinJ Skipper, H J Stauss
Behring Institute Mitteilungen|July 1, 1994
T cell epitopes in human papilloma virus proteinsE Sadovnikova, H J Stauss
Gene Therapy|June 28, 2013
Immunotherapy with gene-modified T cells: limiting side effects provides new challengesH J Stauss, E C Morris
Biochemical Society Transactions|May 1, 1997
Tumour-reactive cytotoxic T-lymphocytes specific for normal cellular proteinsH J Stauss, M Dahl, E Sadovnikova
Leukemia|August 1, 1993
T cell recognition of a point mutation in the P21 Ras proteinL Yin, P Lowe, H J Stauss
Pageof 5

Showing results (1-10 of 50) with videos related to

Sort By:
Pageof 5
Immunology Today|April 22, 1999
Immunotherapy with CTLs restricted by nonself MHCH J Stauss
Journal of the National Cancer Institute|December 20, 1995
Mutant Ras proteins and peptides: bad news for tumorsH J Stauss
Clinical and Experimental Immunology|July 27, 2001
Benign autoimmunity to combat malignancyH J Stauss
Current Biology : CB|October 1, 1991
Peptides feeling groovyH J Stauss
Proceedings of the National Academy of Sciences of the United States of America|November 12, 1996
Peptide-specific cytotoxic T lymphocytes restricted by nonself major histocompatibility complex class I molecules: reagents for tumor immunotherapyE Sadovnikova, H J Stauss
The Journal of Experimental Medicine|May 1, 1993
Identification of two cytotoxic T lymphocyte-recognized epitopes in the Ras proteinJ Skipper, H J Stauss
Behring Institute Mitteilungen|July 1, 1994
T cell epitopes in human papilloma virus proteinsE Sadovnikova, H J Stauss
Gene Therapy|June 28, 2013
Immunotherapy with gene-modified T cells: limiting side effects provides new challengesH J Stauss, E C Morris
Biochemical Society Transactions|May 1, 1997
Tumour-reactive cytotoxic T-lymphocytes specific for normal cellular proteinsH J Stauss, M Dahl, E Sadovnikova
Leukemia|August 1, 1993
T cell recognition of a point mutation in the P21 Ras proteinL Yin, P Lowe, H J Stauss
Pageof 5